Reading the news these days, it seems the word “vaccine” automatically refers to the COVID-19 vaccine, no matter the context. But it’s important not to forget about research coming out about other vaccines as well. That’s especially true since multiple studies have found that childhood immunization rates have fallen during the pandemic.
One of the most recent studies that deserves some coverage is a research letter published April 27 in JAMA that found in national data that only 16% of men aged 18-21 had ever received at least one dose of the human papillomavirus (HPV) vaccine. The HPV vaccine has long struggled to gain a foothold among U.S. youth, but 16% falls well short of the 42% of women in the same age range who had received at least one dose. Continue reading
It can be challenging to keep track of all details associated with the authorization, data and ongoing studies related to COVID-19 vaccines. I’ve written previously about the range of Covid-19 vaccine trackers for all vaccines in development worldwide. But those are less helpful when you need the nitty-gritty data for the vaccines already authorized in the U.S. Continue reading
With most major health systems using patient portals for scheduling COVID-19 vaccinations, many older adults may need help setting up accounts. This situation is considered especially true for those older people with lower incomes and education levels, according to data from the National Poll on Healthy Aging at the University of Michigan Institute for Healthcare Policy and Innovation.
The poll finds that 45% of adults aged 65 to 80, and 42% of all adults aged 50 to 80, said they had not set up an account with their health provider’s portal system. Continue reading
I’ve written previously on Covering Health about the potential harms of reporting on surveys and polls about people’s intent to get the COVID-19 vaccine. In late September, the FDA had not yet authorized any vaccines, so any poll or survey questions were theoretical. Now that vaccines are in distribution, however, does that change things?
Well, yes and no. At that time, I also wrote that vaccine hesitancy wasn’t what we needed to worry about— instead, it was access and equity. Continue reading
Journalists reporting on the rollout of the COVID-19 vaccine have a new tool to guide their coverage: a Vaccine Education Toolkit that includes survey results on audience attitudes and needs, B-roll and multimedia, webinars, recommended experts and tips on reaching specific audiences. This resource may be a helpful complement to the AHCJ’s extensive resources on reporting about the pandemic.
The bilingual website was developed by three groups: the National Association of Broadcasters (NAB), the Donald W. Reynolds Journalism Institute (RJI) and the National Association of Chain Drug Stores (NACDS). RJI is a part of the Missouri School of Journalism and the NACDS is an industry trade group representing traditional drug stores, supermarkets and mass merchants with pharmacies. Continue reading